Beijing Tiantan Biologic. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Tiantan Biologic. with three other
companies in this sector in China:
China Biologic Products Holdings Inc
sales of 3.09 billion Chinese Renmimbi [US$449.04 million]
of which 32%
was Human Albumin),
Tonghua Dongbao Medicines Company Limited
(2.69 billion Chinese Renmimbi [US$390.42 million]
of which 87%
was Pharmaceutical), and
Hualan Biological Engineering Inc
(3.22 billion Chinese Renmimbi [US$467.29 million]
of which 75%
was Blood Product).
Beijing Tiantan Biologic. reported sales of 2.93 billion Chinese Renmimbi (US$425.76 million)
December of 2018.
increase of 66.0%
versus 2017, when the company's sales were 1.77 billion Chinese Renmimbi.